On the presence of C2-ceramide in mammalian tissues: Possible relationship to etherphospholipids and phosphorylation by ceramide kinase

Biological Chemistry

Volumn 388, Issue 3, 2007, Pages 315-324

  Van Overloop, Helena ^a   Denizot, Yves ^b   Baes, Myriam ^a   Van Veldhoven, Paul P ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF LIMOGES   (France)

Author keywords

Acetyl CoA; Ceramide; Lyso PAF; Peroxisomes; Platelet activating factor; Zellweger syndrome

Indexed keywords

CERAMIDE; CERAMIDE KINASE; PHOSPHOLIPID; THROMBOCYTE ACTIVATING FACTOR; CERAMIDE 1 PHOSPHATE; CERAMIDE 1-PHOSPHATE; DRUG DERIVATIVE; ETHER PHOSPHOLIPID; N ACETYLSPHINGOSINE; N-ACETYLSPHINGOSINE; PHOSPHOTRANSFERASE; SPHINGOSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; ENZYME SUBSTRATE; FEMALE; LIPID BRAIN LEVEL; LIPID LIVER LEVEL; LIPOGENESIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ZELLWEGER SYNDROME; ANIMAL; CHO CELL; CRICETULUS; HAMSTER; ISOLATION AND PURIFICATION; METABOLISM; MOUSE; PHOSPHORYLATION;

MAMMALIA; MUS;

ANIMALS; CERAMIDES; CHO CELLS; CRICETINAE; CRICETULUS; MICE; PHOSPHOLIPID ETHERS; PHOSPHORYLATION; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PLATELET ACTIVATING FACTOR; SPHINGOSINE;

EID: 33847644133     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2007.035     Document Type: Article

References (51)

1. Abe, A., Shayman, J.A., and Radin, N.S. (1996). A novel enzyme that catalyzes the esterification of N-acetylsphingosine. Metabolism of C2 ceramides. J. Biol. Chem. 271, 14383-14389.
2. Ardail, E., Popa, I., Bodennec, J., Famy, C., Loiusot, P., and Portoukalian, J. (2002). Subcellular distribution and metabolic fate of exogenous ceramides taken up by HL-60 cells. Biochim. Biophys. Acta 1583, 305-310.
3. Bacchur, N.R. and Udenfriend, S. (1966). Microsomal synthesis of fatty acid amides. J. Biol. Chem. 241, 1308-1313.
4. Bae, K., Longobardi, L., Karasawa, K., Malone, B., Inoue, T., Aoki, J., Arai, H., Inoue, K., and Lee, T. (2000). Platelet-activating factor (PAF)-dependent transacetylase and its relationship with PAF acetylhydrolases. J. Biol. Chem. 275, 26704-26709.
5. Baes, M., Gressens, P., Baumgart, E., Carmeliet, P., Casteels, M., Fransen, M., Evrard, P., Fahimi, E., Declercq, P.E., Collen, D., et al. (1997). A mouse model for Zellweger syndrome. Nat. Genet. 17, 49-56.
6. Bayliss, M.A., Homer, R.B., and Shepherd, M.J. (1988). Determination of diethylene glycol in wine by high-performance liquid chromatography using anthracene-9-carbonyl chloride as a derivatizing reagent. J. Chromatogr. 445, 403-408.
7. Bernardo, K., Hurwitz, R., Zenk, T., Desnick, R.J., Ferlinz, K., Schuchman, E., and Sandhoff, K. (1995). Purification, characterization, and biosynthesis of human acid ceramidase. J. Biol. Chem. 270, 11098-11102.
8. Bodennec, J., Koul, Aguado, I., Brichon, G., Zwingelstein, G., and Portoukalian, J. (2000). A procedure for fractionation of sphingolipid classes by solid-phase extraction on aminopropyl cartridges. J. Lipid Res. 41, 1542-1530.
9. Causeret, C., Geeraert, L., Van der Hoeven, G., Mannaerts, G.P., and Van Veldhoven, P.P. (2000). Further characterization of rat dihydroceramide desaturase: tissue distribution, subcellular localization, and substrate specificity. Lipids 35, 1117-1125.
10. Das, A.K., Holmes, R.D., Wilson, G.N., and Hajra, A.K. (1992). Dietary ether lipid incorporation into tissue plasmalogens of humans and rodents. Lipids 27, 401-405.
11. Denizot, Y., Gainant, A., Guglielmi, L., Bouvier, S., Cubertafond, P., and Mathonnet, M. (2003). Tissue concentrations of platelet-activating factor in colorectal carcinoma: inverse relationships with Dukes' stage of patients. Oncogene 22, 7222-7224.
12. Dupuis, F., Levasseur, S., Jean-Louis, F., Dulery, C., Praloran, V., Denizot, Y., and Michel, L. (1997). Production, metabolism and effect of platelet-activating factor on the growth of the human K562 erythroid cell line. Biochim. Biophys. Acta 1359, 241-249.
13. Futerman, A.H. and Hannun, Y.A. (2004). The complex life of simple sphingolipids. EMBO Rep. 5, 777-782.
14. Gijsbers, S., Mannaerts, G.P., Himpens, B., and Van Veldhoven, P.P. (1999). N-Acetyl-sphingenine-1-phosphate is a potent calcium mobilizing agent. FEBS Lett. 453, 269-272.
15. Gómez-Muñoz, A., Duffy, P.A., Martin, A., O'Brien, L., Byun, H.S., Bittman, R., and Brindley, D.N. (1995). Short chain ceramide-1-phosphates are novel stimulators of DNA synthesis and cell division: antagonism by cell-permeable ceramides. Mol. Pharmacol. 47, 833-839.
16. Goto, J., Goto, N., Shamsa, F., Saito, M., Komatsu, S., Suzaki, K., and Nambara, T. (1983). New sensitive derivatization of hydroxysteroids for high-performance liquid chromatography with fluorescence detection. Anal. Chim. Acta 147, 397-400.
17. Hassler, D.F. and Bell, R.M. (1993). Ceramidases: enzymology and metabolic roles. Adv. Lipid Res. 26, 49-57.
18. Hogback, S., Leppimaki, P., Rudnas, B., Bjorklund, S., Slotte, J.P., and Tornquist, K. (2003). Ceramide 1-phosphate increases intracellular free calcium concentrations in thyroid FRTL-5 cells: evidence for an effect mediated by inositol 1,4,5-trisphosphate and intracellular sphingosine 1-phosphate. Biochem. J. 370, 111-119.
19. Iwamori, M, Costello, C., and Moser, H.W. (1979) Analysis and quantitation of free ceramide containing nonhydroxy and 2-hydroxy fatty acids, and phytosphingosine by high-performance liquid chromatography. J. Lipid Res. 20, 86-96.
20. Janssen, A., Gressens, P., Grabenbauer, M., Baumgart, E., Schad, A., Vanhorebeek, I., Brouwers, A., Declercq, P.E., Fahimi, D., Evrard, P., et al. (2003). Neuronal migration depends on intact peroxisomal function in brain and in extraneuronal tissues. J. Neurosci. 23, 9732-9741.
21. Kashiwagi, M., Mikami, T., Chiba, M., Chiba, S., Matsumoto, H., Akino, T., and Gasa, S. (1997). Occurrence of nonenzymatic N-acetylation of sphinganine with acetyl coenzyme A producing C2-H2-ceramide and its inconvertibility to apoptotic C2-ceramide. Biochem. Mol. Biol. Intern. 42, 1071-1080.
22. King, C.M., Land, S.L., Jones, R.F., Debiec-Rychter, M., Lee, M.S., and Wang, C.Y. (1997). Role of acetyltransferases in the metabolism and carcinogenicity of aromatic amines. Mutat. Res. 376, 123-128.
23. Komori, H. and Ito, M. (1995). Conversion of short chain ceramides to short chain ceramide GM3 in B16 melanoma cells. FEBS Lett. 374, 299-302.
24. Kunievsky, B. and Yavin, E. (1994). Production and metabolism of platelet-activating factor in the normal and ischemic fetal rat brain. J. Neurochem. 63, 2144-2151.
25. Lee, T.C., Ou, M.C, Shinozaki, K., Malone, B., and Snyder, F. (1996). Biosynthesis of N-acetylsphingosine by platelet-activating factor:sphingosine CoA-independent transacetylase in HL-60 cells. J. Biol. Chem. 271, 209-217.
26. Levade, T., Malagarie-Cazenave, S., Gouaze, V., Segui, B., Tardy, C., Betito, S., Andrieu-Abadie, N., and Cuvillier, O. (2002). Ceramide in apoptosis: a revisited role. Neurochem. Res. 27, 601-607.
27. Mannaerts, G.P. and Van Veldhoven, P.P. (1993). Metabolic pathways in mammalian peroxisomes. Biochimie 75, 147-158.
28. Merrill, A.H. Jr., Sullards, M.C., Wang, E., Voss, K.A., and Riley, R.T. (2001) Sphingolipid metabolism: roles in signal transduction and disruption by fumonisins. Environ. Health Perspect. 109, 283-289.
29. Montrucchio, G., Sapino, A., Bussolati, B., Ghisolfi, G., Rizea-Savu, S., Silvestro, L., Lupia, E., and Camussi, G. (1998). Potential angiogenic role of platelet-activating factor in human breast cancer. Am. J. Pathol. 153, 1589-1596.
30. Murphy, R.C. (1993). Mass Spectrometry of Lipids (New York, USA: Plenum Press).
31. Nishida, K., Markey, S.P., Kustova, Y., Morse, H.C. III, Skolnick, P., Basile, A.S., and Sei, Y. (1996). Increased brain levels of platelet-activating factor in a murine acquired immune deficiency syndrome are NMDA receptor-mediated. J. Neurochem. 66, 433-435.
32. Noda, A., Ono, Y., Wu, X., Kudo, F., Jitsefuchi, N., Eto, S., and Noda, H. (1995). Determination and properties of acetyl conjugate of N-desisopropylpropanolol, AcDNP. Biol. Pharm. Bull. 18, 1454-1455.
33. Pettus, B.J., Baes, M., Busman, M., Hannun, Y.A., and Van Veldhoven, P.P. (2004). Mass spectrometric analysis of ceramide perturbations in brain and fibroblasts of mice and human patients with peroxisomal disorders. Rapid Commun. Mass Spectrom. 18, 1569-1574.
34. Prescott, S.M., Zimmerman, G.A., Stafforini, D.M., and McIntyre, T.M. (2000). Platelet-activating factor and related lipid mediators. Annu. Rev. Biochem. 69, 419-445.
35. Ridgway, N.D. and Merriam, D.L. (1995). Metabolism of short chain ceramide and dihydroceramide analogues in Chinese hamster ovary (CHO) cells. Biochim. Biophys. Acta 1256, 57-70.
36. Sim, E., Payton, M., Noble, M., and Minchin, R. (2000). An update on genetic, structural and functional studies of arylamine N- acetyltransferases in eukaryotes and prokaryotes. Hum. Mol. Genet. 9, 2435-2441.
37. Snyder, F. (1990). Platelet-activating factor and related acetylated lipids as potent biologically active cellular mediators. Am. J. Physiol. 259, C697-708.
38. Sturk, A., Schaap, M.C., Prins, A.J., ten Cate, W., Govaerts, L.C., Wanders, R.J.A., Heymans, H.S., and Schutgens, R.B. (1987). Age-related deficiency of the synthesis of platelet activating factor by leukocytes from Zellweger patients. Blood 70, 460-463.
39. Suga, K., Kawasaki, T., Blank, M.L., and Snyder, F. (1990). An arachidonoyl (polyenoic)-specific phospholipase A2 activity regulates the synthesis of platelet-activating factor in granulocytic HL-60 cells. J. Biol. Chem. 265, 12363-12371.
40. Sugiura, M., Kono, K., Liu, H., Shimizugawa, T., Minekura, H., Spiegel, S., and Kohama, T. (2002). Ceramide kinase, a novel lipid kinase. J. Biol. Chem. 277, 23294-23300.
41. Tiberghien, C., Laurent, L., Junier, M.P., and Dray, F. (1991). A competitive receptor binding assay for platelet-activating factor (PAF): quantification of PAF in rat brain. J. Lipid Mediat. 3, 249-266.
42. Tornquist, K., Blom, T., Shariatmadari, R., and Pasternack, M. (2004). Ceramide 1-phosphate enhances calcium entry through voltage-operated calcium channels by a protein kinase C-dependent mechanism in GH4C1 rat pituitary cells. Biochem. J. 380, 661-668.
43. Tserng, K.Y. and Griffin, R. (2003) Quantification and molecular species determination of diacylglycerols, phosphatidylcholines, ceramides, and sphingomyelins with gas chromatography. Anal. Biochem. 323, 84-93.
44. Uemura, Y., Lee, T.C., and Snyder, F. (1991). A coenzyme A-independent transacylase is linked to the formation of platelet-activating factor (PAF) by generating the lyso-PAF intermediate in the remodeling pathway. J. Biol. Chem. 266, 8268-8272.
45. Valsecchi, M., Mauri, L., Casellato, R., Prioni, S., Loberto, N., Prinetti, A., Chigorno, V., and Sonnino, S. (2006). Ceramide and sphingomyelin species of fibroblasts and neurons in culture. J. Lipid Res., in press, doi:10.1194/jlr.M600344-JLR200.
46. Van Overloop, H., Gijbers, S., and Van Veldhoven, P.P. (2006). Further characterization of mammalian ceramide kinase: substrate delivery and (stereo)specificity, tissue distribution, and subcellular localization studies. J. Lipid Res. 47, 268-283.
47. Van Veldhoven, P.P. and Bell, R.M. (1988). Effect of harvesting methods, growth conditions and growth phase on diacylglycerol levels in cultured human adherent cells. Biochim. Biophys. Acta 959, 185-196.
48. 3H]alkyl-2-arachidonoyl-sn-glycero- 3-phosphorylcholine to lyso platelet-activating factor by the CoA-independent transacylase in membrane fractions of human neutrophils. J. Biol. Chem. 266, 18691-18698.
49. Venable, M.E., Zimmerman, G.A., McIntyre, T.M., and Prescott, S.M. (1993). Platelet-activating factor: a phospholipid autacoid with diverse actions. J. Lipid Res. 34, 691-702.
50. Wanders, R.J. (2004). Peroxisomes, lipid metabolism, and peroxisomal disorders. Mol. Genet. Metab. 83, 16-27.
51. Yamaoka, S., Miyaji, M., Kitano, T., Umehara, H., and Okazaki, T. (2004). Expression cloning of a human cDNA restoring sphingomyelin synthesis and cell growth in sphingomyelin synthase-defective lymphoid cells. J. Biol. Chem. 279, 18688-18693.